West Pharmaceutical Services, Inc. (WST)

NYSE: WST · Real-Time Price · USD
210.97
+5.38 (2.62%)
May 27, 2025, 4:00 PM - Market closed
2.62%
Market Cap 15.16B
Revenue (ttm) 2.90B
Net Income (ttm) 467.20M
Shares Out 71.85M
EPS (ttm) 6.37
PE Ratio 33.06
Forward PE 33.11
Dividend $0.84 (0.40%)
Ex-Dividend Date Jul 30, 2025
Volume 558,380
Open 208.87
Previous Close 205.59
Day's Range 208.71 - 211.20
52-Week Range 187.43 - 352.33
Beta 1.14
Analysts Strong Buy
Price Target 349.00 (+65.45%)
Earnings Date Apr 24, 2025

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc... [Read more]

Sector Healthcare
Founded 1923
Employees 10,600
Stock Exchange NYSE
Ticker Symbol WST
Full Company Profile

Financial Performance

In 2024, WST's revenue was $2.89 billion, a decrease of -1.92% compared to the previous year's $2.95 billion. Earnings were $492.70 million, a decrease of -16.97%.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for WST stock is "Strong Buy." The 12-month stock price forecast is $349.0, which is an increase of 65.45% from the latest price.

Price Target
$349.0
(65.45% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

69 May Aristocrats: Buy 1 Of 38 "Safer" Dividend Dogs

Many S&P 500 Dividend Aristocrats remain overvalued, but select high-yield 'Dogs' like Realty Income and Amcor offer attractive entry points for income investors. Analyst forecasts suggest the top ten...

7 days ago - Seeking Alpha

West to Participate in Upcoming Investor Conferences

EXTON, Pa. , May 7, 2025 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will prese...

19 days ago - PRNewsWire

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. (WST)

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pen...

20 days ago - GlobeNewsWire

Best Dividend Aristocrats For May 2025

Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Ed...

27 days ago - Seeking Alpha

West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag

West Pharmaceutical Services, Inc. WST on Thursday reported first-quarter 2025 adjusted EPS of $1.45, beating the consensus of $1.23.

4 weeks ago - Benzinga

West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chairman...

4 weeks ago - Seeking Alpha

West Pharma raises profit forecast as dollar weakens amid Trump's tariff policies

West Pharmaceutical Services raised its annual profit forecast on Thursday, anticipating a boost from a weaker dollar to shield it from a potential hit from U.S. President Donald Trump's tariffs.

4 weeks ago - Reuters

West Announces Leadership Changes

Bernard J. Birkett Announces Intention to Retire from West, Company Initiates Search for a Successor Shane Campbell Appointed Senior Vice President, Chief Proprietary Segment Officer EXTON, Pa. , Apri...

4 weeks ago - PRNewsWire

West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.

4 weeks ago - PRNewsWire

West to Host First-Quarter 2025 Conference Call

EXTON, Pa. , April 10, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will rel...

6 weeks ago - PRNewsWire

Best Dividend Aristocrats For April 2025

Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Br...

Other symbols: ABBVABTADMBDXBENBROCAH
2 months ago - Seeking Alpha